$4.39 -0.37 (-7.77%)
3/16/2010 4:00 PM

EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Featured Broker Partners